2023
24
February
2023
|
07:52
Europe/Amsterdam
BIOTRONIK announced today that it has received CE approval for the Selectra 3D implant tools to include left bundle branch area pacing (LBBAP) in addition to His-bundle pacing (HBP). Commonly referred to as conduction system pacing (CSP) these two ap...
Read more
2021
20
August
2021
|
11:58
Europe/Amsterdam
BIOTRONIK has today announced an important online symposium hosting the principal investigator of the TRUST Trial1, the latest study calling for a reform to the current clinical standards for in-person patient evaluations (IPE), as part of this year’...
Read more
03
June
2021
|
09:15
Europe/Amsterdam
For cardiology patients fitted with an implantable cardioverter-defibrillator (ICD) or pacemaker, remote monitoring is a blessing: knowing that the implant is being monitored for technical and medical abnormalities during office hours provides enormo...
Read more
2020
23
January
2020
|
00:00
Europe/Amsterdam
BIOTRONIK this month announced the market release of its new injectable cardiac monitor (ICM), BIOMONITOR III. The novel device is designed to help patients with irregular heart rhythms by documenting unexplained syncope with increased clarity.
As...
Read more
2019
22
July
2019
|
00:00
Europe/Amsterdam
BIOTRONIK today announced the publication of the SENSE Trial results in the Journal of Cardiac Electrophysiology, proving BIOTRONIK’s DX system is equivalent to dual-chamber implantable cardioverter defibrillators (ICDs) in detecting atrial high-rate...
Read more
08
July
2019
|
00:00
Europe/Amsterdam
BIOTRONIK today announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to document suspected arrhythmia or unexplained syncope with increased clarity, enabling fast diagnosis and appropriate treatme...
Read more
28
June
2019
|
00:00
Europe/Amsterdam
BIOTRONIK today announced the market release of its new injectable cardiac monitor (ICM), BIOMONITOR III, following approval in the CE region. The novel device is designed to help patients with irregular heart rhythms by documenting suspected arrhyth...
Read more
27
May
2019
|
00:00
Europe/Amsterdam
BIOTRONIK announced today that the first patient for the BIO|MASTER.Cor Family study was enrolled at Pauls Stradins Clinical University Hospital in Riga, Latvia at the cardiology department led by Prof. Andrejs Erglis. The patient received a Rivacor ...
Read more
06
May
2019
|
00:00
Europe/Amsterdam
BIOTRONIK today announced initial enrollment into the BIO-LIBRA study, a first-of-its kind, large-scale prospective study to analyze sex-specific outcomes in patients with non-ischemic cardiomyopathy (NICM) treated with cardiac defibrillator device t...
Read more
06
May
2019
|
00:00
Europe/Amsterdam
The observational THORN registry1 highlights the importance of rapid corrective action by medical staff in cases of inappropriate diagnosis and therapy using implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy defibri...
Read more
29
April
2019
|
00:00
Europe/Amsterdam
BIOTRONIK announced today the availability of its Plexa ProMRI S DX lead, with DF4/IS-1 connector in Europe and the US. The lead is an extension of BIOTRONIK’s Plexa family. Together with the new lead and recently launched Acticor/Rivacor ICD and CRT...
Read more
29
April
2019
|
00:00
Europe/Amsterdam
BIOTRONIK today announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Leading electrophysiologists throughout the United States are now treating patients with the new implantable cardioverter defi...
Read more
01
April
2019
|
00:00
Europe/Amsterdam
BIOTRONIK today announced the launch of its Acticor 7 ICD and CRT-D families, which offer a variety of features that specifically address the needs of Japanese patients. The devices are only 10 mm slim and come with an elliptical BIOshape as well as ...
Read more
14
March
2019
|
00:00
Europe/Amsterdam
BIOTRONIK today announced FDA approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for treatment of patients with cardiac arrhythmias. The six new tachycardia solutions include Rivacor VR-T, Rivacor DR-T, R...
Read more
11
March
2019
|
00:00
Europe/Amsterdam
BIOTRONIK today announced the European market release of the world’s smallest ICD and CRT-D devices that are approved for 3 Tesla (3T) full-body MRI scans.1
Devices in the Acticor and Rivacor families are only 10 mm slim, with a smooth and ellipti...
Read more
04
March
2019
|
00:00
Europe/Amsterdam
Two-year data from the RM-ALONE Trial1 evaluating the safety and workflow efficiency of remote cardiac monitoring with remote interrogations were recently published in the European Heart Journal. The authors analyzed the efficacy of BIOTRONIK Home Mo...
Read more
27
February
2019
|
00:00
Europe/Amsterdam
BIOTRONIK, the University of Newcastle and the Hunter New England Local Health District (HNE LHD) have partnered to shape a future heart failure care model. Investments by the Australian government and BIOTRONIK have kicked off the partnership, recog...
Read more
2018
17
December
2018
|
00:00
Europe/Amsterdam
BIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK’s CRT-...
Read more
27
August
2018
|
00:00
Europe/Amsterdam
BIOTRONIK today announced that the company is now the exclusive US distributor for InfoBionic’s MoMe Kardia external cardiac diagnostic monitor. The device benefits patients suspected of experiencing cardiac arrhythmias.
Patients experiencing card...
Read more
21
June
2018
|
00:00
Europe/Amsterdam
Today BIOTRONIK and GenesisCare started a three-year strategic partnership to enhance outcomes for cardiac patients in Australia. The new partners will initiate interdisciplinary research projects focusing on better data sharing, care pathways and in...
Read more
03
April
2018
|
00:00
Europe/Amsterdam
BIOTRONIK US and Aziyo today announced a strategic agreement allowing BIOTRONIK to distribute Aziyo’s CanGaroo® extracellular matrix (ECM) cardiovascular implantable electronic device (CIED) envelopes in the United States. BioEnvelope will be availab...
Read more
01
March
2018
|
00:00
Europe/Amsterdam
BIOTRONIK’s latest offering of pacemaker systems, now approved for 3 tesla (T) full-body MRI scans (FBS), launched in Japan today. The Evity series of single- (SR-T) and dual-chamber (DR-T) pacemakers are outfitted with MRI AutoDetect, which automati...
Read more
2017
04
October
2017
|
00:00
Europe/Amsterdam
BIOTRONIK’s exclusive rate responsive technology, Closed Loop Stimulation (CLS) has shown to reduce fainting in pacemaker patients with vasovagal syncope up to sevenfold. Results from the SPAIN study, the first prospective double-blind placebo-contro...
Read more
29
August
2017
|
00:00
Europe/Amsterdam
The European Heart Rhythm Association (EHRA) released the analytical supplement to the 10th EHRA White Book during the ESC Congress 2017 in Barcelona.
Supported by BIOTRONIK, the EHRA White Book is the annual collection of data about the number of...
Read more
24
August
2017
|
00:00
Europe/Amsterdam
Cardiology experts will present conclusive results from various BIOTRONIK studies at the European Society of Cardiology’s ESC Congress 2017.
The presentations and discussions will shed light on recent advances in the treatment of atrial fibrillati...
Read more
21
August
2017
|
00:00
Europe/Amsterdam
BIOTRONIK today announced FDA approval and commercial availability of Edora HF-T QP, an MR conditional quadripolar (QP) cardiac resynchronization therapy pacemaker (CRT-P) with MRI AutoDetect technology.
With a volume of 15 cc, Edora HF-T QP is th...
Read more
03
August
2017
|
00:00
Europe/Amsterdam
BIOTRONIK’s highest performing cardiac resynchronization therapy defibrillator (CRT-D) is now available in Japan. With several key technologies, the Intica 7 HF-T QP has been developed to offer physicians all-inclusive and individualized solutions fo...
Read more
19
July
2017
|
00:00
Europe/Amsterdam
BIOTRONIK today announced FDA approval and availability of the Intica DX and Intica cardiac resynchronization therapy (CRT)-DX implantable cardioverter defibrillator (ICD) systems. The launch of Intica CRT-DX extends the proven benefits of BIOTRONIK’...
Read more
19
June
2017
|
00:00
Europe/Amsterdam
Experts in heart failure management gathered today to discuss varying scientific evidence in their field and how to transfer results into clinical practice. The BIOTRONIK symposium “CRT in 2017: Remaining Challenges and New Opportunities in Heart Fai...
Read more
13
June
2017
|
00:00
Europe/Amsterdam
BIOTRONIK received CE approval for 3 tesla (T) full-body scans (FBS) with its latest range of MR conditional pacemaker systems. Patients implanted with single- and dual-chamber pacemakers from the Edora/Evity/Enitra series can now benefit from ultra-...
Read more
